Potential pitfalls in the use of surrogate endpoints in colorectal adenoma chemoprevention

Journal of the National Cancer Institute

Volumn 95, Issue 10, 2003, Pages 697-699

  Levin, Bernard ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; APC PROTEIN; ASCORBIC ACID; BETA CAROTENE; CELECOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN P53;

ALCOHOL CONSUMPTION; CANCER INCIDENCE; CANCER MORTALITY; CANCER RESEARCH; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON ADENOMA; COLONOSCOPY; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE MARKER; EDITORIAL; ENDOSCOPIC POLYPECTOMY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; ONCOGENE K RAS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECTUM ADENOMA; RISK BENEFIT ANALYSIS; SMOKING; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0037603588     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.10.697     Document Type: Editorial

References (20)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
3. Jass JR. Pathogenesis of colorectal cancer. Surg Clin N Am 2002;82: 891-904.
4. Peipins LA, Sandler RS. Epidemiology of colorectal adenomas. Epidemiol Rev 1994;16:273-9.
5. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancers by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
6. Young GP, Rozen P, Levin B. How does colorectal cancer develop? In: Rozen P, Young G, Levin B, Spann S, editors. Colorectal cancer in clinical practice: prevention, early detection and management. London (UK): Martin Dunitz; 2002. p. 23-37.
7. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
8. Smalley W, Ray WA, Daugherty J, Griffin MR. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 1999;159:161-6.
9. O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ, et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 2002;8:314-46.
10. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
11. Hawk ET, Limburg PJ, Viner JL. Epidemiology and prevention of colorectal cancer. Surg Clin N Am 2002;82:905-41.
12. Greenberg ER, Baron JA, Tosteson TD, Freeman DH Jr, Beck GJ, Bond JH, et al. A clinical trial of antioxidant vitamins to prevention colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 1994;331:141-7.
13. Baron JA, Cole BF, Mott L, Haile R, Grau M, Church TR, et al. Neoplastic and antineoplastic effect of beta-carotene on colorectal adenoma. J Natl Cancer Inst 2003;95:717-22.
14. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
15. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
16. Greenwald P. Beta-carotene and lung cancer: a lesson for future chemoprevention investigations? J Natl Cancer Inst 2003;95:E1.
17. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, et al. Randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883-90.
18. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevention colorectal adenomas. N Engl J Med 2003;348:891-9.
19. Rashid A, Zahurak M, Goodman SN, Hamilton SR. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut 1999;44:826-33.
20. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, Edwards S, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000;92:1831-36.